BMO Capital Reiterates Market Perform on Casey's General Stores (CASY) Following 2Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Jefferies Raises Price Target on Casey's General Stores (CASY) Following 2Q Earnings Report
December 9, 2016 7:06 AM ESTJefferies reiterated a Buy rating on Casey's General Stores (NASDAQ: CASY), and raised the price target to $143.00 (from $128.00), following the company's 2Q earnings report. CASY reported adjusted EPS of $1.45, compared to the consensus of $1.59. EBITDA of $149M missed the consensus estimate of $154M.
Analyst... More
After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
December 7, 2016 7:04 PM ESTToday's After-Hours Movers:
Voyager Therapeutics, Inc. (Nasdaq: VYGR) 35.2% HIGHER; announced positive results from the ongoing Phase 1b trial of VY-AADC01 at six and twelve months of follow-up in patients with advanced Parkinsons disease. The interim data from Cohorts 1 and 2 of this trial demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamen, increased AADC enzyme activity, enhanced response to levodopa, and dose-related, clinically meaningful improvements in various measures of patients motor function. This was... More
Casey's General Stores (CASY) Misses Q2 EPS by 15c
December 7, 2016 4:42 PM ESTCasey's General Stores (NASDAQ: CASY) reported Q2 EPS of $1.44, $0.15 worse than the analyst estimate of $1.59. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.94 billion.
For the quarter, same-store gallons sold were up 3.7% with an average margin above... More
